Hollysys (HOLI US): Keep Calm as Closing Date Slips

443 Views17 Apr 2024 02:14
The spread has widened to 8% due to regulatory approval concerns. Regulatory approval should be forthcoming as the transaction involves Chinese entities acquiring a Chinese-focused company.
What is covered in the Full Insight:
  • Transaction Delay Explanation
  • Closing Conditions Status
  • Chinese Regulatory Approvals Introduction
  • NDRC, MOFCOM and SAFE Procedures
  • Reasons why regulatory approvals should be forthcoming
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x